Patent · US Active

Anti-GITR antibodies

US8709424B2 · kind B2 · utility

54Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2010
Grant dateApr 29, 2014
Priority date—
Expiry dateAug 31, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies to human GITR are provided, as well as uses thereof, e.g., in treatment of proliferative and immune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.